Literature DB >> 30132722

Differential Radiation Sensitivity in p53 Wild-Type and p53-Deficient Tumor Cells Associated with Senescence but not Apoptosis or (Nonprotective) Autophagy.

Jingwen Xu1, Nipa H Patel2,3, Tareq Saleh2,3, Emmanuel K Cudjoe4, Moureq Alotaibi5, Yingliang Wu1, Santiago Lima6,3, Adam M Hawkridge4,3, David A Gewirtz2,3.   

Abstract

Studies of radiation interaction with tumor cells often focus on apoptosis as an end point; however, clinically relevant doses of radiation also promote autophagy and senescence. Moreover, functional p53 has frequently been implicated in contributing to radiation sensitivity through the facilitation of apoptosis. To address the involvement of apoptosis, autophagy, senescence and p53 status in the response to radiation, the current studies utilized isogenic H460 non-small cell lung cancer cells that were either p53-wild type (H460wt) or null (H460crp53). As anticipated, radiosensitivity was higher in the H460wt cells than in the H460crp53 cell line; however, this differential radiation sensitivity did not appear to be a consequence of apoptosis. Furthermore, radiosensitivity did not appear to be reduced in association with the promotion of autophagy, as autophagy was markedly higher in the H460wt cells. Despite radiosensitization by chloroquine in the H460wt cells, the radiation-induced autophagy proved to be essentially nonprotective, as inhibition of autophagy via 3-methyl adenine (3-MA), bafilomycin A1 or ATG5 silencing failed to alter radiation sensitivity or promote apoptosis in either the H460wt or H460crp53 cells. Radiosensitivity appeared to be most closely associated with senescence, which occurred earlier and to a greater extent in the H460wt cells. This finding is consistent with the in-depth proteomics analysis on the secretomes from the H460wt and H460crp53 cells (with or without radiation exposure) that showed no significant association with radioresistance-related proteins, whereas several senescence-associated secretory phenotype (SASP) factors were upregulated in H460wt cells relative to H460crp53 cells. Taken together, these findings indicate that senescence, rather than apoptosis, plays a central role in determination of radiosensitivity; furthermore, autophagy is likely to have minimal influence on radiosensitivity under conditions where autophagy takes the nonprotective form.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30132722      PMCID: PMC7141768          DOI: 10.1667/RR15099.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  92 in total

Review 1.  The role of p53 in determining sensitivity to radiotherapy.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

2.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  The Challenge of Developing Autophagy Inhibition as a Therapeutic Strategy.

Authors:  David A Gewirtz
Journal:  Cancer Res       Date:  2016-09-15       Impact factor: 12.701

4.  Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion.

Authors:  Caroline Mauvezin; Thomas P Neufeld
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

5.  Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.

Authors:  Yu-Long Hu; Michael DeLay; Arman Jahangiri; Annette M Molinaro; Samuel D Rose; W Shawn Carbonell; Manish K Aghi
Journal:  Cancer Res       Date:  2012-03-23       Impact factor: 12.701

6.  TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition.

Authors:  Santiago Lima; Kazuaki Takabe; Jason Newton; Kumar Saurabh; Megan M Young; Andreia Machado Leopoldino; Nitai C Hait; Jane L Roberts; Hong-Gang Wang; Paul Dent; Sheldon Milstien; Laurence Booth; Sarah Spiegel
Journal:  Autophagy       Date:  2018-03-11       Impact factor: 16.016

7.  Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?

Authors:  Molly L Bristol; Sean M Emery; Paola Maycotte; Andrew Thorburn; Shweta Chakradeo; David A Gewirtz
Journal:  J Pharmacol Exp Ther       Date:  2013-01-04       Impact factor: 4.030

8.  The autophagy-senescence connection in chemotherapy: must tumor cells (self) eat before they sleep?

Authors:  Rachel W Goehe; Xu Di; Khushboo Sharma; Molly L Bristol; Scott C Henderson; Kristoffer Valerie; Francis Rodier; Albert R Davalos; David A Gewirtz
Journal:  J Pharmacol Exp Ther       Date:  2012-08-27       Impact factor: 4.030

Review 9.  Chemotherapy Resistance in Lung Cancer.

Authors:  Eric S Kim
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

10.  A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.

Authors:  Myrna R Rosenfeld; Xiaobu Ye; Jeffrey G Supko; Serena Desideri; Stuart A Grossman; Steven Brem; Tom Mikkelson; Daniel Wang; Yunyoung C Chang; Janice Hu; Quentin McAfee; Joy Fisher; Andrea B Troxel; Shengfu Piao; Daniel F Heitjan; Kay-See Tan; Laura Pontiggia; Peter J O'Dwyer; Lisa E Davis; Ravi K Amaravadi
Journal:  Autophagy       Date:  2014-05-20       Impact factor: 16.016

View more
  11 in total

1.  Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells.

Authors:  Nipa H Patel; Jingwen Xu; Tareq Saleh; Yingliang Wu; Santiago Lima; David A Gewirtz
Journal:  Biochem Pharmacol       Date:  2020-03-03       Impact factor: 5.858

Review 2.  The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib.

Authors:  Laurence A Booth; Jane L Roberts; Paul Dent
Journal:  Semin Cancer Biol       Date:  2019-10-20       Impact factor: 15.707

Review 3.  Autophagy and cancer treatment: four functional forms of autophagy and their therapeutic applications.

Authors:  Zhaoshi Bai; Yaling Peng; Xinyue Ye; Zhixian Liu; Yupeng Li; Lingman Ma
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

Review 4.  The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation.

Authors:  Nipa H Patel; Sahib S Sohal; Masoud H Manjili; J Chuck Harrell; David A Gewirtz
Journal:  Radiat Res       Date:  2020-08-01       Impact factor: 2.841

5.  Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer.

Authors:  Shao-Yuan Chen; Koichi Tsuneyama; Mao-Hsiung Yen; Jiunn-Tay Lee; Jiun-Liang Chen; Shih-Ming Huang
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 6.  Dual effects of active ERK in cancer: A potential target for enhancing radiosensitivity.

Authors:  Yinliang Lu; Baocai Liu; Ying Liu; Xinyue Yu; Guanghui Cheng
Journal:  Oncol Lett       Date:  2020-05-28       Impact factor: 2.967

7.  Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response.

Authors:  Danny Feijtel; Gabriela N Doeswijk; Nicole S Verkaik; Joost C Haeck; Daniela Chicco; Carmelina Angotti; Mark W Konijnenberg; Marion de Jong; Julie Nonnekens
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

8.  The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.

Authors:  Margarita Pustovalova; Lina Alhaddad; Taisia Blokhina; Nadezhda Smetanina; Anna Chigasova; Roman Chuprov-Netochin; Petr Eremin; Ilmira Gilmutdinova; Andreyan N Osipov; Sergey Leonov
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

9.  Dual inhibition of DNA-PK and DNA polymerase theta overcomes radiation resistance induced by p53 deficiency.

Authors:  Rashmi J Kumar; Hui Xiao Chao; Dennis A Simpson; Wanjuan Feng; Min-Guk Cho; Victoria R Roberts; Aurora R Sullivan; Sonam J Shah; Anne-Sophie Wozny; Katerina Fagan-Solis; Sunil Kumar; Adam Luthman; Dale A Ramsden; Jeremy E Purvis; Gaorav P Gupta
Journal:  NAR Cancer       Date:  2020-12-21

10.  Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo.

Authors:  Daniel P Radin; Gregory Smith; Victoria Moushiaveshi; Alexandra Wolf; Robert Bases; Stella E Tsirka
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.